Qiushi Xu
Papers
1
Total Citations
3
H-Index
1
About
Qiushi Xu is a rising clinician-researcher specializing in urologic pathology and rare renal neoplasms, with a particular focus on angiomyolipoma variants and their genetic underpinnings. Xu’s most cited work investigates the exceptionally rare entity of renal angiomyolipoma with epithelial cysts (AMLEC) lacking a visible fat component—a diagnostic challenge that mimics malignancy. In a landmark 2024 case report, Xu identified a TSC1 splicing mutation in a 29-year-old male patient, providing the first molecular evidence linking this specific genetic alteration to fat-deficient AMLEC. This contribution has already garnered 3 citations, signaling its value to pathologists and urologists navigating ambiguous renal masses. By elucidating the genotype–phenotype correlation in this ultra-rare subtype, Xu’s research helps reduce unnecessary radical nephrectomies and advances precision diagnosis in renal tumor pathology. The work underscores Xu’s commitment to bridging clinical observation with molecular validation, offering critical insights for both surgical decision-making and the understanding of TSC-associated tumorigenesis. As Xu continues to build a portfolio in rare genitourinary tumors, this early impact marks the beginning of a promising career in translational uropathology.
Research Focus
Key Achievements
Top Papers
- 1